Pharming Group N.V. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,844.00
21,186.00
10,828.00
15,873.00
89,620.00
135,130
Cost of Goods Sold (COGS) incl. D&A
1,453.50
3,949.00
5,346.00
5,439.00
15,860.00
25,925
Gross Income
5,390.50
17,237.00
5,482.00
10,434.00
73,760.00
109,205
SG&A Expense
11,994.00
14,465.00
18,463.00
22,309.00
52,638.00
71,897
EBIT
7,018.00
2,772.00
12,981.00
11,540.00
21,122.00
37,308
Unusual Expense
12.00
9,106.00
3,380.00
79.00
63,929.00
495
Non Operating Income/Expense
190.00
562.00
423.00
11.00
6,015.00
21,663
Interest Expense
7,931.00
175.00
898.00
6,069.00
52,610.00
14,311
Pretax Income
15,060.00
5,767.00
9,957.00
17,536.00
89,399.00
857
Income Tax
-
-
-
-
9,442.00
24,136
Consolidated Net Income
15,060.00
5,767.00
9,957.00
17,536.00
79,957.00
24,993
Net Income
15,060.00
5,767.00
9,957.00
17,536.00
79,957.00
24,993
Net Income After Extraordinaries
15,060.00
5,767.00
9,957.00
17,536.00
79,957.00
24,993
Net Income Available to Common
15,060.00
5,767.00
9,957.00
17,536.00
79,957.00
24,993
EPS (Basic)
0.07
0.01
0.02
0.04
0.16
0.04
Basic Shares Outstanding
214,607.60
396,098.50
411,749.50
415,381.30
500,412.80
606,618.10
EPS (Diluted)
0.07
0.01
0.02
0.04
0.16
0.04
Diluted Shares Outstanding
214,607.60
396,098.50
411,749.50
415,381.30
500,412.80
653,527.70
EBITDA
6,097.50
3,810.00
12,435.00
10,784.00
24,537.00
41,243
Other Operating Expense
414.50
-
-
335.00
-
-
Non-Operating Interest Income
91.00
180.00
119.00
5.00
3.00
18
About Pharming Group
View Profile
